Agenda

DAY 1
DAY 2
Session II
HER 2+
Friday, September 12, 2025
1:45 pm
3:10 pm
Session Moderator(s)
PRESENTATION IN THIS SESSION

Session Introduction

Reshma L. Mahtani, DO

Optimizing Treatment for Early Stage HER2 Positive Breast Cancer

Ana C. Garrido-Castro, MD

Optimizing Sequencing of Therapy for Metastatic HER2 Positive Breast Cancer

Ana C. Sandoval Leon, MD

What's on the Horizon: Novel Strategies in HER2 Positive Breast Cancer

Heather L. McArthur, MD, MPH, FASCO

Audience Q&A and Panel Discussion

Ana C. Garrido-Castro, MD; Heather L. McArthur, MD, MPH; Ana C. Sandoval Leon, MD